Jian Xiao

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming-Ming He, Jian Xiao et al. · Clinical Cancer Research · 2022 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study

Yunyu Mao, Qibin Liao, Youwei Zhu et al. · Cell Discovery · 2024 · 56 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

De‐Shen Wang, Chao Ren, Shanshan Li et al. · PLoS Medicine · 2024 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery

Yonghe Chen, Dan Liu, Jian Xiao et al. · Gastroenterology Research and Practice · 2021 · 12 citations · Full text

Medicine, Oncology, Surgery +17